Pre- and Post TAVI Cognitive Functioning and Intraoperative Carotid Flow Measurements
Usability Study of the BAMCOG Followed by Concurrent Validation of the BAMCOG With the MoCA as a Monitoring Instrument for Perioperative Cognitive Function
1 other identifier
observational
54
1 country
1
Brief Summary
Purpose:
- 1.Measuring and optimize the usability of the BAMCOG (games to measure cognitive functioning)
- 2.Concurrent validation of BAMCOG with MoCA to see if BAMCOG can serve as a monitoring instrument/screener
- 3.Determination of carotid flow/cerebral blood flow pre- and post implant of prosthesis of aortic valve by ultrasound doppler measurements
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFirst Submitted
Initial submission to the registry
April 3, 2023
CompletedFirst Posted
Study publicly available on registry
April 14, 2023
CompletedApril 14, 2023
April 1, 2023
1.5 years
April 3, 2023
April 3, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Usability of BAMCOG
3 months preoperative
Concurrent validation of BAMCOG with MoCA
3 months preoperative - 3 months postoperative
Cerebral perfusion/carotid flow measurements
Peroperative
Eligibility Criteria
Elderly patients undergoing TAVI surgery
You may qualify if:
- \> 65 years old
- Scheduled for TAVI surgery
- Able to play games on a tablet
- For usability part \> MoCA score of 26 or higher
- Near native dutch speaker
You may not qualify if:
- Mental disorder (unable to play games)
- Alcohol abuse (women \<15 and men \>22 alcoholic drinks/week)
- No informed consent
- Atrial fibrillitation (for ultrasound doppler)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Catharina Hospital
Eindhoven, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Drs. Mariska te Pas
Study Record Dates
First Submitted
April 3, 2023
First Posted
April 14, 2023
Study Start
July 14, 2021
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
April 14, 2023
Record last verified: 2023-04